Clinical trial / 2019
Flaxseed and psyllium improved constipation symptoms, weight, glycemia, and lipids compared to placebo in constipated patients with type 2 diabetes.
In a 12-week single-blinded trial, 77 constipated patients with type 2 diabetes received cookies containing 10 g flaxseed, 10 g psyllium, or placebo twice daily. Compared to placebo, both flaxseed and psyllium groups showed significant improvements from baseline in constipation symptoms (P = 0.002), stool consistency (P < 0.001), weight (P < 0.001), BMI (P < 0.001), fasting plasma glucose (P = 0.004), cholesterol (P = 0.010), LDL cholesterol (P = 0.031), and cholesterol/HDL cholesterol ratio (P = 0.019). Flaxseed appeared superior to psyllium for improving these markers, and no adverse effects were observed.
- Study type
- Single-blinded randomized controlled trial
- Who was studied
- 77 constipated patients with type 2 diabetes
- What was measured
- Constipation symptoms, BMI, FPG, HbA1c, and lipid profile
THE PAPER
Effect of flaxseed or psyllium vs. placebo on management of constipation, weight, glycemia, and lipids: A randomized trial in constipated patients with type 2 diabetes.
Soltanian N, Janghorbani M. Clin Nutr ESPEN, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.